Engineered bacterial cells and methods of producing the same
AssigneeUchicago Argonne, LLC
InventorsMichael Fonstein, Paul D. Hanke, Bruce Parrello, Rick Stevens, Thomas S. Brettin, Christopher S. Henry
Life of this patent
Estimating the term…
Loading patent…
AssigneeUchicago Argonne, LLC
InventorsMichael Fonstein, Paul D. Hanke, Bruce Parrello, Rick Stevens, Thomas S. Brettin, Christopher S. Henry
Estimating the term…
The present disclosure provides novel engineered target-biomolecule-producing bacterial strains and methods of producing the same. To engineer bacterial strains capable of producing substantial levels of a target biomolecule, the methods may implement the use of metabolic modeling and machine learning methods. The methods and bacterial strains produced by the methods may be implemented in further optimizing a biosynthetic pathway, e.g., to improve the production of a target biomolecule of interest, e.g., an amino acid, such as threonine.
A method of engineering a target-biomolecule-producing bacterial cell, the method comprising:
An engineered bacterial cell capable of producing threonine, wherein the engineered bacterial cell comprises a chromosome comprising a metL deletion.
Dependencies are inferred from the claim text.